Anuh Pharma Ltd.
Snapshot View

95.15 +3.10 ▲3.4%

02 December 2022, 04:01:00 PM
Volume: 43,950

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.anuhpharma.com
Market Cap 477.57 Cr.
Enterprise Value(EV) 472.85 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 6.71 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 14.20 Trailing Twelve Months Ending 2022-09
Industry PE 35.40 Trailing Twelve Months Ending 2022-09
Book Value / Share 44.34 Trailing Twelve Months Ending 2022-09
Price to Book Value 2.15 Calculated using Price: 95.30
Dividend Yield 1.84 Period Ending 2022-03
No. of Shares Subscribed 5.01 Cr. 50,112,000 Shares
FaceValue 5
Company Profile
Anuh Pharma incorporated in 1960, is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The company is part of the SK Group, which has evolved as a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+3.37%
1 Week
+3.48%
1 Month
+2.59%
3 Month
+2.20%
6 Month
+1.39%
1 Year
-6.62%
2 Year
-32.40%
5 Year
+4.39%
10 Year
+278.48%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 21.78 23.55 23.44 15.43 11.38 14.87 8.75 16.12 15.11
Return on Capital Employed (%) 32.94 35.13 34.91 21.61 16.31 20.56 10.87 19.75 19.33
Return on Assets (%) 11.75 13.29 14.37 10.58 8.35 10.44 5.06 8.63 8.99

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 86 101 119 141 150 165 162 191 214 222
Non Curr. Liab. 1 0 0 0 0 0 1 3 3 2
Curr. Liab. 77 67 72 47 59 75 163 139 131 114
Minority Int.
Equity & Liab. 163 168 191 187 208 239 326 333 347 338
Non Curr. Assets 22 24 40 50 54 87 103 95 88 90
Curr. Assets 142 144 151 138 154 152 223 238 259 248
Misc. Exp. not W/O
Total Assets 163 168 191 187 208 239 326 333 347 338

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 266 284 326 206 238 321 307 432 487 492
Other Income 4 5 4 8 7 5 4 11 5 4
Total Income 271 289 330 214 245 325 311 443 492 496
Total Expenditure -242 -253 -289 -183 -220 -291 -284 -387 -439 -441
PBIDT 28 36 41 30 26 35 27 56 53 55
Interest -1 -1 -1 -1 0 -1 -1 -2 -2 -1
Depreciation -2 -3 -2 -2 -2 -2 -7 -15 -12 -11
Taxation -8 -10 -12 -8 -7 -9 -5 -10 -9 -10
Exceptional Items
PAT 18 22 26 20 17 23 14 28 31 34
Adjusted EPS 4 4 5 4 3 5 3 6 6 7

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 2 15 19 17 26 2 7 49 -19 29
Cash Fr. Inv. 4 -5 -12 -5 -20 2 3 -77 52 -8
Cash Fr. Finan. -6 -8 -8 -9 -4 -5 -7 22 -33 -19
Net Change 0 2 -1 2 2 -1 3 -5 0 2
Cash & Cash Eqvt 0 2 1 3 5 4 7 2 2 4

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 71.19 70.46 70.47 70.43 70.43 70.45 70.43 70.58 70.58
Public 28.81 29.54 29.53 29.57 29.57 29.55 29.57 29.42 29.42
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 15 Nov 2022
Disclosure Of Related Party Transactions Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and SEBI Circular bearing reference no. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22 2021 please find enclosed herewith the disclosure of Related Party Transactions for the half year ended 30th September 2022.Submitted for your information and records.
Tue, 08 Nov 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
Ref: Scrip Code No. 506260Sub: Newspaper Publication of Unaudited Financial Results for the quarter ended 30.09.2022Please find enclosed herewith the copy of newspaper advertisement with respect to the Unaudited Financial Results for the quarter ended September 30 2022 published in the Financial Express and Mumbai Lakshadeep on Tuesday November 08 2022 in compliance with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015.Kindly acknowledge the receipt and take the same on record.
Tue, 08 Nov 2022
Sub: Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015. Noting Of Resignation Of Mr. Bharat Gangani From The Post Of Company Secretary And Compliance Officer Of The Company.
Dear Sir/Madam Pursuant to the provisions of Regulation 30 read with Schedule III Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended this is to inform you that the Board of Directors of the Company (the "Board") at its Meeting held on Monday 7th November 2022 has noted the resignation of Mr. Bharat Gangani from the post of Company Secretary and Compliance Officer of the Company.Company has already made an intimation regarding the resignation of Mr. Bharat Gangani as a Company Secretary and Compliance Officer to the Stock Exchange on 20th October 2022.The Meeting of the Board of Directors commenced at 12:30 PM and concluded at 3:15 PM.

Technical Scans View Details >>

Fri, 02 Dec 2022
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Closing Above Previous High Closing Above Previous High

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,530.84 1,040.00 -0.6%
Cipla Ltd. 89,936.23 1,114.35 -0.9%
Divi's Laboratories Ltd. 89,761.56 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. 75,098.21 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. 70,043.98 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. 54,931.39 1,623.05 -1.2%
Max Healthcare Institute Ltd. 43,491.25 448.10 -0.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.50 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-09 35.23 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 29.99 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 24.23 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 83.18 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 68.92 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-09 46.09 448.10 -0.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.68 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-09 4.13 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 7.40 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.63 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.67 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.02 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-09 6.29 448.10 -0.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 448.10 -0.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 448.10 -0.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 448.10 -0.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 448.10 -0.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 448.10 -0.9%

FAQ's On Anuh Pharma Ltd.

What is Anuh Pharma share price?

Can I buy Anuh Pharma shares now?

What is the Dividend Yield of Anuh Pharma?

What is the Market Cap of Anuh Pharma?

What are the key metrics to analyse Anuh Pharma?

What is the 52 Week High and Low of Anuh Pharma?

What is the trend of Anuh Pharma share price?